Related Articles
Antitumor activities of dFv-LDP-AE: An enediyne-energized fusion protein targeting tumor-associated antigen gelatinases
MMP-2/9-oriented combinations enhance antitumor efficacy of EGFR/HER2-targeting fusion proteins and gemcitabine
Small antibody fusion proteins with complementarity‑determining regions and lidamycin for tumor targeting therapy
An albumin‑binding domain and targeting peptide‑based recombinant protein and its enediyne‑integrated analogue exhibit directional delivery and potent inhibitory activity on pancreatic cancer with K‑ras mutation
Factor VII light chain-targeted lidamycin targets tissue factor-overexpressing tumor cells for cancer therapy